Clinical significance of detectable and quantifiable HCV RNA at the end of treatment with ledipasvir/sofosbuvir in GT1 patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical significance of detectable and quantifiable HCV RNA at the end of treatment with ledipasvir/sofosbuvir in GT1 patients

Published:2018-08-10 Issue:11 Volume:38 Page:1906-1910
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Maasoumy Benjamin¹^ORCID,Buggisch Peter²,Mauss Stefan³,Boeker Klaus H. W.⁴,Müller Tobias⁵^ORCID,Günther Rainer⁶,Zimmermann Tim⁷,Manns Michael P.¹,Sarrazin Christoph⁸⁹,Hüppe Dietrich¹⁰,Wedemeyer Heiner¹¹¹¹²^ORCID,Vermehren Johannes⁸

Affiliation:

1. Hannover Medical School; Hannover Germany

2. IFI-Institute for Interdisciplinary Medicine; Hamburg Germany

3. Center for HIV and Hepatogastroenterology; Duesseldorf Germany

4. Leberpraxis Hannover; Hannover Germany

5. Charité Campus Virchow-Klinikum (CVK); Berlin Germany

6. Universitätsklinikum Schleswig-Holstein; Kiel Germany

7. University Medical Center of the Johannes Gutenberg University Mainz; Mainz Germany

8. St. Josef-Hospital; Wiesbaden Germany

9. University Hospital Frankfurt; Frankfurt am Main Germany

10. Hepatologische Schwerpunktpraxis Herne; Herne Germany

11. Leberstiftungs-GmbH Deutschland; Hannover Germany

12. Department of Gastroenterology and Hepatology; University Hospital Essen, University of Duisburg Essen; Essen Germany

Funder

Gilead Sciences

Merck Sharp and Dohme

Janssen Pharmaceuticals

F. Hoffmann-La Roche

Deutsches Zentrum für Infektionsforschung

Bristol-Myers Squibb

AbbVie Deutschland

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13932/fullpdf

Reference11 articles.

1. Diagnostics in hepatitis C: the end of response-guided therapy;Maasoumy;J Hepatol,2016

2. AASLD/IDSA HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C www.hcvguidelines.org

3. Clinical significance of residual viremia detected by two real-time PCR assays for response-guided therapy of HCV genotype 1 infection;Vermehren;J Hepatol,2014

4. Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens;Maasoumy;J Hepatol,2016

5. Utility of hepatitis C viral load monitoring on direct-acting antiviral therapy;Sidharthan;Clin Infect Dis,2015

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does a detectable HCV RNA at the end of DAA therapy herald treatment failure?;Antiviral Research;2023-12

2. Meta‐analysis: diagnostic accuracy of hepatitis C core antigen detection during therapy with direct‐acting antivirals;Alimentary Pharmacology & Therapeutics;2022-08-28

3. Real‐world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R);Zeitschrift für Gastroenterologie;2022-07-15

4. Immunological Characteristics of Patients Receiving Ultra-Short Treatment for Chronic Hepatitis C;Frontiers in Cellular and Infection Microbiology;2022-06-27

5. Breakthroughs in hepatitis C research: from discovery to cure;Nature Reviews Gastroenterology & Hepatology;2022-05-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3